We Grow Unicorns
Precision Medicine through a female lens
hexTeam3 | T10 | UNICORN |
---|---|---|
T23 | hexTeam1 | |
T27 |
We are Europe's only dedicated women's health investment fund. Investing since 2021 and now raising a £100mn fund, we invest in pioneering technology businesses built to offer personalised healthcare to the four billion women worldwide.
About
At Goddess Gaia Ventures ("GGV"), we are pioneering the future of women’s health by focusing our investment strategy on addressing the unique needs and challenges faced by women.
​
As a female-founded and managed venture capital fund, our mission is to revolutionize the $1.1 trillion women’s healthcare market by investing in transformative technologies and solutions across five investments verticals:
-
Female Fertility
-
Female Cancers
-
Female Wellness & Sports
-
Chronic Diseases
-
Femtech Products and Services.
​​
We recognize that women's healthcare has long been overlooked and underfunded, despite women comprising over half of the global population. Shockingly, only 4% of all healthcare research and funding is allocated to women’s health, with 65% of that focused on fertility. This imbalance highlights the urgent need for a dedicated, specialised, female-driven approach to women’s healthcare investment.
​
At GGV, we are not just investing in promising companies; we are investing in a vision for change. Our all-female founding team brings a unique perspective and a deep understanding of the challenges women face.
Through our Pre-Series A investments, we invest in visionary entrepreneurs who are committed to building extraordinary companies that will redefine healthcare and improve lives on a global scale.
We are always on the lookout for the next big idea. If you are passionate about revolutionizing women’s health and are ready to make a difference, we would love to connect with you. Join us in shaping the future of women's healthcare.
Get in touch — we are excited to meet you and explore how we can make an impact together.​
Team
PRIYA OBEROI
FOUNDING GENERAL PARTNER
Oxford Alumni | Founder of PE firm Oberoi Capital Partners | Entrepreneur and Founder | Ex Lawyer | Working Mother | Cancer Survivor
Priya is the General Partner of Goddess Gaia Ventures (GGV). Priya conceptualised and started to build GGV in 2021 after a long-held belief that women’s healthcare is greatly underserved and underfunded and there remains huge, untapped market potential in this investment vertical.
Priya is an avid angel investor and has demonstrated access and a winning formula when investing in promising start-ups.
​
Priya is also the founder of Oberoi Capital Partners. She built, managed and ran the investment firm for over ten years, providing fund raising expertise, strategic business advice and multi-channel scale-up positioning across different asset classes and distinct investment strategies.
Priya is a finance and derivatives lawyer by background and training, attaining of-counsel recognition in 2010 at a magic circle law firm.
​
Priya holds a B.A. (Hons) and MA in Jurisprudence from the University of Oxford.
​
​
AYA SUZUKI, CFA
HEAD OF OPERATIONS, PARTNER
Waseda Alumni | Chartered Financial Analyst | Ex Capital Markets Banker | Cross Border Transactions | Working Mother
Aya is an experienced banker, having worked for 12 years at UBS Investment Bank in London and Tokyo. Aya worked as a Debt Capital Markets professional focusing on deal execution, business development and client relationship management experience.
Aya not only has an exceptional technical background, but also understands the importance of collaboration, out-of-the-box thinking, technology, mentorship and D&I.
She was most recently responsible for the origination, distribution and execution of private placements for a broad range of institutional clients worldwide and has extensive experience delivering cross-border solutions for her clients. She is bilingual in English and Japanese.
Aya holds a B.A. in Economics from Waseda University, Japan.
LAUREN GEORG
ASSOCIATE
LSE Alumni | Startups & VC | Adventurer
Lauren has worked in an array of sectors from Consulting, Marketing to Investment Associate across multiple industries ranging from FinTech to Venture Capital. Lauren has had a first-hand experience working both within emerging and well-established start-ups as well as the financing of such ventures which gives her an extensive understanding of the ecosystem.
Lauren blends an analytical background with creativity, communication and adaptability in order to deliver at the highest level.
She has experience in deal sourcing and leading due diligence processes as well as venture platform management, marketing and investor relations. She is bilingual in English and French.
Lauren holds a BSc in Management from London School of Economics and Political Sciences.
MARISSA K FAYER
GGV INVESTMENT COMMITTEE MEMBER
Boston University alumni | Entrepreneur | Angel and Impact Investor | HERhealthEQ Social-Impact CEO/Founder | Women’s Health CEO and Executive |TEDx Speaker | Engineer | US and Emerging Markets Company Builder | Medical Device and MedTech +20 years | Miller Center Fellow
Marissa has spent the last 22 years growing Medical Device companies into world-class organizations with a distinct blend of Engineering, Operations, Quality, Product Development, and tactical skills. She is a strategic advisor and board member of several venture-backed private companies and has taken on executive leadership in several of the companies she has worked with. Marissa is a UCSC Miller Center Social Entrepreneur Fellow and has been listed as one of the Top 100 Women in Medtech.
Marissa holds a Bachelor of Science in Engineering from Boston University and an MBA from the University of Connecticut.
MARIA MOLLAND
GGV INVESTMENT COMMITTEE MEMBER
Harvard Business School | Northwestern university alumni | Executive | Entrepreneur | Investor | Board Member | Exited Founder at Thinx Inc | Frazier Healthcare Partners
As the former CEO and Board Member of Thinx, a feminine hygiene company specializing in period underwear, Maria transformed a struggling $10M business into a thriving $130M+ global brand. Under her leadership, Thinx achieved disruptive success with a robust culture, a top-tier product available in various distribution channels, and a strategic sale to Kimberly Clark in early 2022. Maria adeptly managed challenges, including the Covid-19 pandemic and a class action lawsuit, while securing a $25M Series A fundraise.
​
Maria serves on multiple boards, advises startups, and partners with a European venture capital firm to scale their health and wellness portfolio globally. She is a prominent speaker on entrepreneurship, capital raising, and profitable scaling. Passionate about female leadership, women's health, and sustainability, Maria brings extensive experience to her diverse roles.
​
Maria holds a Bachelor in Economics from Northwestern University and an MBA from Harvard Business School.